… Lindsay Strowd has received grants or support from Galderma, Pfizer, Actelion, and Sanofi
Regeneron. Steven Feldman has received research, speaking, and/or consulting support …

Methods A PubMed search was conducted using the search terms “graft versus host disease,”“acute
GVHD,”“chronic GVHD,”“pathophysiology,”“diagnosis,” and “treatment.” Selection of …

… Dr Lindsay Strowd has received consulting fees or research funding from Galderma, Lilly,
Pfizer, Sanofi, and Actelion, and reports grants from Pfizer, CME writing from Galderma, …

Background: Scabies is a neglected skin disease, and little is known about current incidence
and treatment patterns in the United States. The purpose of this study was to examine …

Background Atopic dermatitis is a chronic inflammatory skin condition that affects up to 20%
of children and 3% of adults globally. Although topical corticosteroids are considered to be …

… Feldman has received grant and consulting honoraria from Pfizer, and is a consultant to and
has received grants from Regeneron and Sanofi; Dr Cox is a consultant to Pfizer; Dr Strowd …

Skin cancer is the most common malignancy in the United States. 1 Globally, it is estimated
that more than 1 million new cases of nonmelanoma skin cancer (NMSC) were diagnosed in …

Background Patient outcomes are improved when dermatologists provide inpatient
consultations. Inpatient access to dermatologists is limited, illustrating an opportunity to use …

Importance Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) is known to
cause multiple end-organ complications in its acute phase, but less is known about the long-…

… Meanwhile, L Strowd has received research support, speaking fees and/or consulting
support from AbbVie, Pfizer, Sanofi, Regeneron, Galderma and Novartis. The authors have no …